Commentary: can mortality rates among adult antiretroviral therapy patients in Europe reach levels similar to those experienced in the general population?

Comment

Andrew F Auld et al. Int J Epidemiol. 2012 Apr.

. 2012 Apr;41(2):445-7.

doi: 10.1093/ije/dys023. Epub 2012 Mar 6.

No abstract available

Conflict of interest statement

Conflict of interest: None declared.

All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord; Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, d'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, et al. Int J Epidemiol. 2012 Apr;41(2):433-45. doi: 10.1093/ije/dyr164. Epub 2011 Nov 28. Int J Epidemiol. 2012. PMID: 22493325

1. Bhaskaran K, Hamouda O, Sannes M et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 2008;300: 51–59. - PubMed
1. Zwahlen M, Harris R, May M et al. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol 2009;38:1624–33. - PMC - PubMed
1. Lewden C, Chene G, Morlat P et al. HIV-infected adults with a CD4 cell count greater than ⩾500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 2007;46:72–77. - PubMed
1. French AL, Gawel SH, Hershow R et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr 2009;51:399–406. - PMC - PubMed
1. Lewden C, Bouteloup V, De Wit S et al. All-cause mortality in treated HIV-infected adults with CD4 ⩾500 /mm³ compared to the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2012;41:433–45. - PubMed